INTERNATIONAL PATENT: IMMUNOBIOCHEM CORPORATION FILES APPLICATION FOR "DEGRADER DRUG CONJUGATES AND METHODS OF USE THEREOF"

GENEVA, Jan. 25 -- IMMUNOBIOCHEM CORPORATION (1055 Bay StreetSuite 2007Toronto, Ontario M5S 3A3) filed a patent application (PCT/CA2025/050982) for "DEGRADER DRUG CONJUGATES AND METHODS OF USE THEREOF" on Jul 16, 2025. With publication no. WO/2026/015981, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NESCHADIM, Anton (1055 Bay StreetSuite 2007Toronto, Ontario M5S 3A3)

Abstract: Conjugation reagents for making, and targeted degrader conjugates made therefrom, comprising a Janus family kinase binder and a CD127 binding a...